DEF 14A: Coliseum Acquisition Corp. Seeks Extension to Complete Business Combination with Rain Enhancement Technologies
Proxy Statement
Coliseum Acquisition Corp. is seeking shareholder approval to extend the deadline for completing its business combination with Rain Enhancement Technologies, while also removing the ability to use trust account interest for dissolution expenses.
Summary
- Coliseum Acquisition Corp. is requesting shareholder approval for several amendments to its governing documents.
- The primary goal is to extend the deadline for completing a business combination from December 25, 2024, to December 31, 2024, with the possibility of further extensions to February 28, 2025.
- These extensions are contingent on the company's new sponsor contributing additional funds to the trust account, with an initial deposit of $17,500 and subsequent monthly deposits of $75,000.
- The company also proposes to remove the ability to use up to $100,000 of interest earned on the trust account for dissolution expenses, which would increase the per-share payout to shareholders if the company liquidates.
- These proposals are cross-conditioned, meaning all must be approved for any to take effect.
- If the proposals are not approved, the company will be forced to liquidate, returning funds to shareholders after deducting up to $100,000 for dissolution expenses.
- The company is working towards a business combination with Rain Enhancement Technologies (RET), but needs more time to complete the transaction.
- The company's securities may be delisted from Nasdaq if the business combination is not completed by December 23, 2024, and may be quoted on the OTC market.
Sentiment
Score: 4
Explanation: The document indicates a need for further extensions and potential delisting, which are negative signals. However, the new sponsor's financial commitment and the potential for a higher payout in liquidation provide some positive aspects. Overall, the sentiment is cautiously negative.
Positives
- The proposed extension provides additional time to complete the business combination with RET.
- Removing the ability to use trust account interest for dissolution expenses increases the potential payout to shareholders in the event of liquidation.
- Shareholders have the option to redeem their shares for a price higher than the current market price.
- The new sponsor is providing additional funding to support the extension.
Negatives
- The company's securities may be delisted from Nasdaq if the business combination is not completed by December 23, 2024.
- The company has already extended its deadline multiple times.
- The company may be forced to liquidate if the proposals are not approved.
- There is no guarantee that the business combination with RET will be completed even with the extension.
Risks
- The business combination with RET may not be completed by the extended deadline.
- The company's securities may be delisted from Nasdaq.
- The company may be forced to liquidate if the proposals are not approved.
- Redemptions by shareholders could leave the company with insufficient cash to complete the business combination.
- The company may be deemed an investment company under the Investment Company Act, which could lead to liquidation.
- The business combination may be subject to review by the Committee on Foreign Investment in the United States (CFIUS), which could delay or prevent the transaction.
Future Outlook
The company intends to continue working towards completing the business combination with RET and may extend the deadline further if necessary, subject to shareholder approval and additional funding from the new sponsor. The company also intends to have its securities quoted on the OTC market if delisted from Nasdaq.
Management Comments
- The Board believes that in order to be able to successfully complete the Business Combination, it is appropriate to obtain the New Extension.
- The Board has determined that each of the Extension Amendment Proposal, the Dissolution Expenses Amendment Proposal, the Trust Amendment Proposal, and the Adjournment Proposal are in the best interests of the Company and its shareholders, and has declared it advisable and unanimously recommends that you vote or give instruction to vote FOR such Proposals.
Industry Context
This announcement is typical for SPACs that are approaching their deadline to complete a business combination. The need for extensions and additional funding is common in the SPAC market, reflecting the challenges in finding and completing suitable transactions within the initial timeframe. The potential delisting from Nasdaq highlights the regulatory pressures and time constraints faced by SPACs.
Comparison to Industry Standards
- The need for multiple extensions is not uncommon among SPACs, especially those facing challenges in completing a business combination within the initial timeframe.
- The financial contributions from the new sponsor are similar to what is seen in other SPAC extension scenarios, where sponsors provide additional capital to extend the timeline.
- The redemption price of approximately $11.36 per share is typical for SPACs holding funds in trust, reflecting the pro-rata share of the trust account balance.
- The potential delisting from Nasdaq and transition to the OTC market is a common outcome for SPACs that fail to meet listing requirements, similar to other SPACs that have faced similar challenges.
- The cross-conditioning of the proposals is a common tactic to ensure all necessary amendments are approved to facilitate the extension.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Amendment to Articles | Extending the deadline for completing a business combination and removing the ability to use trust account interest for dissolution expenses. | Upon shareholder approval and filing with the Cayman Islands Registrar of Companies. | Provides additional time to complete the business combination and increases the potential payout to shareholders in the event of liquidation. |
| Amendment to Trust Agreement | Reflecting the Dissolution Expenses Amendment. | Upon shareholder approval and execution of the amendment. | Ensures the trust agreement aligns with the amended articles, preventing the use of trust account interest for dissolution expenses. |
Related Party Transactions
- The new sponsor is providing additional funding to support the extension, including a loan of up to $1.5 million.
- The new sponsor and its affiliates have made an aggregate of approximately $1.6 million of advances to the Company as of the date of this proxy statement, which will be repaid in cash at the consummation of the Business Combination with RET.
- The Company owes the New Sponsor $170,000 of accrued administrative services fees as of the date of this proxy statement.
- The Company will pay the Sponsor Affiliate an aggregate of $500,000 as reimbursement of out-of-pocket expenses incurred by him related to identifying, investigating, negotiating and completing an initial business combination.
Stakeholder Impact
- Shareholders have the opportunity to redeem their shares for a price higher than the current market price.
- Shareholders will receive a higher per-share payout in the event of liquidation due to the removal of the ability to use trust account interest for dissolution expenses.
- Shareholders face the risk of delisting from Nasdaq and potential liquidation if the business combination is not completed.
- The new sponsor is providing additional funding, which benefits the company and its shareholders.
- The company's directors and officers have interests that may be different from those of other shareholders.
Next Steps
- Shareholders will vote on the proposed amendments at the Extraordinary General Meeting on December 23, 2024.
- If approved, the company will file the amendments to its Articles and continue working towards completing the business combination with RET.
- The company may seek further extensions if necessary, subject to shareholder approval and additional funding from the new sponsor.
- The company will hold a separate shareholder meeting to vote on the business combination with RET at a later date.
Key Dates
| Date | Description |
|---|---|
| June 22, 2021 | Date of the original Investment Management Trust Agreement. |
| June 25, 2021 | Date of the company's initial public offering (IPO). |
| June 22, 2023 | Shareholders approved the First Extension to the business combination deadline. |
| June 21, 2023 | Date of Amendment No. 1 to the Investment Management Trust Agreement. |
| June 25, 2024 | Company entered into the Business Combination Agreement with RET and received a delisting notice from Nasdaq. |
| August 8, 2024 | Date of the hearing with the Nasdaq Hearings Panel. |
| August 14, 2024 | Nasdaq granted the company an exception to Nasdaq IM-5101-2. |
| November 25, 2024 | Holdco and RET initially filed the Registration Statement on Form S-4. |
| November 26, 2024 | Record date for the Extraordinary General Meeting and the redemption price per share was approximately $11.36. |
| December 10, 2024 | The Registration Statement on Form S-4 was declared effective by the SEC and the definitive proxy statement/prospectus was filed. |
| December 13, 2024 | Date of the proxy statement. |
| December 19, 2024 | Deadline for shareholders to submit redemption requests. |
| December 23, 2024 | Date of the Extraordinary General Meeting and the deadline to complete the business combination with RET to avoid delisting from Nasdaq. |
| December 25, 2024 | Current Termination Date for the business combination. |
| December 31, 2024 | Proposed Extended Date for the business combination. |
| February 28, 2025 | Potential final Additional Extended Date for the business combination. |
Keywords
business combination, special purpose acquisition company, SPAC, extension, redemption, trust account, dissolution, Rain Enhancement Technologies, RET, Nasdaq, delisting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.